Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1198
Peer-review started: November 14, 2022
First decision: January 12, 2023
Revised: January 20, 2023
Accepted: January 28, 2023
Article in press: January 28, 2023
Published online: February 16, 2023
Processing time: 91 Days and 19 Hours
Regional anesthesia is a promising method in patients with post coronavirus disease 2019 (COVID-19) pulmonary sequelae for preserving pulmonary function and preventing postoperative pulmonary complications, compared with general anesthesia.
We provided surgical anesthesia and analgesia suitable for breast surgery by performing pectoral nerve block type II (PECS-II), parasternal, and intercostobrachial nerve blocks with intravenous dexmedetomidine administration in a 61-year-old female patient with severe pulmonary sequelae after COVID-19 infection.
Sufficient analgesia for 7 h was provided via PECS-II, parasternal, and intercostobrachial blocks perioperatively.
Core Tip: This is the first clinical case report of the application of multiple nerve blocks for breast cancer surgery in a patient with severe post coronavirus disease 2019 (COVID-19) pulmonary sequelae. The use of performing pectoral nerve block type II (PECS-II), parasternal, and intercostobrachial nerve blocks provided sufficient analgesic and anesthetic effects during the perioperative period. Therefore, this case report suggests an alternative anesthetic modality for post COVID-19 patients who are at a high risk of receiving general anesthesia for breast surgery.